Poseida Therapeutics Stock (NASDAQ: PSTX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.000 / 751.083K |
Day Range | - - - |
52 Wk Range | 1.540 - 4.270 |
Market Cap | $208.417M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 5.76% |
Days to Cover | 6.54 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Poseida Therapeutics (NASDAQ: PSTX) through any online brokerage.
Other companies in Poseida Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).
The latest price target for Poseida Therapeutics (NASDAQ: PSTX) was reported by HC Wainwright & Co. on Monday, April 22, 2024. The analyst firm set a price target for 20.00 expecting PSTX to rise to within 12 months (a possible 825.93% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Poseida Therapeutics (NASDAQ: PSTX) is $2.16 last updated April 23, 2024 at 4:14 PM EDT.
There are no upcoming dividends for Poseida Therapeutics.
Poseida Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Poseida Therapeutics.
Poseida Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.